{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T14:48:44Z","timestamp":1794581324365,"version":"4.9.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,7]],"date-time":"2022-05-07T00:00:00Z","timestamp":1651881600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,7]],"date-time":"2022-05-07T00:00:00Z","timestamp":1651881600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","award":["BRC-1215-20014"],"award-info":[{"award-number":["BRC-1215-20014"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EJNMMI Res"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Pituitary adenomas (PA) affect ~\u20091:1200 of the population and can cause a wide range of symptoms due to hormone over-secretion, loss of normal pituitary gland function and\/or compression of visual pathways, resulting in significantly impaired quality of life. Surgery is potentially curative if the location of the adenoma can be determined. However, standard structural (anatomical) imaging, in the form of MRI, is unable to locate all tumors, especially microadenomas (&lt;\u20091\u00a0cm diameter). In such cases, functional imaging [<jats:sup>11<\/jats:sup>C-methionine PET\/CT (Met-PET)] can facilitate tumor detection, although may be inconclusive when the adenoma is less metabolically active. We, therefore, explored whether subtraction imaging, comparing findings between two Met-PET scans with medical therapy-induced suppression of tumor activity in the intervening period, could increase confidence in adenoma localization. In addition, we assessed whether normalization to a reference region improved consistency of pituitary gland signal in healthy volunteers who underwent two Met-PET scans without medical suppression.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We found that the mean percentage differences in maximum pituitary uptake between two Met-PET scans in healthy volunteers were 2.4% for (SUVr) [cerebellum], 8.8% for SUVr [pons], 5.2% for SUVr [gray matter] and 23.1% for the SUVbw [no region]. Laterality, as measured by contrast\u2013noise ratio (CNR), indicated the correct location of the adenoma in all three image types with mean CNR values of 6.2, 8.1 and 11.1 for SUVbw, SUVbwSub and SUVrSub [cerebellum], respectively. Subtraction imaging improved CNR in 60% and 100% of patients when using images generated from SUVbw [no region] and SUVr [cerebellum] scans compared to standard clinical SUVbw imaging.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Met-PET scans should be normalized to the cerebellum to minimize the effects of physiological variation in pituitary gland uptake of 11C-methionine, especially when comparing serial imaging. Subtraction imaging following endocrine suppression of tumor function improved lateralization of PA when compared with single time point clinical Met-PET but, importantly, only if the images were normalized to the cerebellum prior to subtraction.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13550-022-00899-7","type":"journal-article","created":{"date-parts":[[2022,5,7]],"date-time":"2022-05-07T12:05:08Z","timestamp":1651925108000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Localization of TSH-secreting pituitary adenoma using 11C-methionine image subtraction"],"prefix":"10.1186","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9773-6502","authenticated-orcid":false,"given":"Daniel","family":"Gillett","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell","family":"Senanayake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"MacFarlane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merel","family":"van der Meulen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olympia","family":"Koulouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew S.","family":"Powlson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosy","family":"Crawford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bethany","family":"Gillett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"Bird","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Heard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelos","family":"Kolias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Mannion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Aloj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iosif A.","family":"Mendichovszky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heok","family":"Cheow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waiel A.","family":"Bashari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5745-6832","authenticated-orcid":false,"given":"Mark","family":"Gurnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,7]]},"reference":[{"key":"899_CR1","doi-asserted-by":"publisher","first-page":"5","DOI":"10.12703\/P6-5","volume":"6","author":"A Kopczak","year":"2014","unstructured":"Kopczak A, Renner U, Karl SG. Advances in understanding pituitary tumors. F1000Prime Rep. 2014;6:5.","journal-title":"F1000Prime Rep"},{"issue":"2","key":"899_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2019.05.002","volume":"33","author":"WA Bashari","year":"2019","unstructured":"Bashari WA, Senanayake R, Fern\u00e1ndez-Pombo A, Gillett D, Koulouri O, Powlson AS, et al. Modern imaging of pituitary adenomas. Best Pract Res Clin Endocrinol Metab. 2019;33(2): 101278.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"2","key":"899_CR3","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1023\/B:PITU.0000004798.27230.ed","volume":"6","author":"MD Johnson","year":"2003","unstructured":"Johnson MD, Woodburn CJ, Vance ML. Quality of life in patients with a pituitary adenoma. Pituitary. 2003;6(2):81\u20137.","journal-title":"Pituitary"},{"issue":"5","key":"899_CR4","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1007\/s11102-015-0636-7","volume":"18","author":"CD Andela","year":"2015","unstructured":"Andela CD, Scharloo M, Pereira AM, Kaptein AA, Biermasz NR. Quality of life (QoL) impairments in patients with a pituitary adenoma: a systematic review of QoL studies. Pituitary. 2015;18(5):752\u201376.","journal-title":"Pituitary"},{"issue":"4","key":"899_CR5","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1210\/jc.2010-1048","volume":"96","author":"PU Freda","year":"2011","unstructured":"Freda PU, Beckers AM, Katznelson L, Molitch ME, Montori VM, Post KD, et al. Pituitary incidentaloma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(4):894\u2013904.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"899_CR6","doi-asserted-by":"publisher","first-page":"M33","DOI":"10.1530\/EJE-15-0464","volume":"173","author":"LK Nieman","year":"2015","unstructured":"Nieman LK. Cushing\u2019s syndrome: update on signs, symptoms and biochemical screening. Eur J Endocrinol. 2015;173(4):M33\u20138.","journal-title":"Eur J Endocrinol"},{"issue":"11","key":"899_CR7","doi-asserted-by":"publisher","first-page":"3933","DOI":"10.1210\/jc.2014-2700","volume":"99","author":"L Katznelson","year":"2014","unstructured":"Katznelson L, Laws ER Jr, Melmed S, Molitch ME, Murad MH, Utz A, et al. Acromegaly: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2014;99(11):3933\u201351.","journal-title":"J Clin Endocrinol Metab"},{"key":"899_CR8","doi-asserted-by":"crossref","unstructured":"Koulouri O, Steuwe A, Gillett D, Hoole AC, Powlson AS, Donnelly NA, et al. A role for 11C-methionine PET imaging in ACTH-dependent Cushing\u2019s syndrome. Eur J Endocrinol. 2015;173(4).","DOI":"10.1530\/EJE-15-0616"},{"issue":"12","key":"899_CR9","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1016\/S2213-8587(16)30311-4","volume":"4","author":"O Koulouri","year":"2016","unstructured":"Koulouri O, Hoole AC, English P, Allinson K, Antoun N, Cheow H, et al. Localisation of an occult thyrotropinoma with 11 C-methionine PET-CT before and after somatostatin analogue therapy. Lancet Diabetes Endocrinol. 2016;4(12):1050.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"899_CR10","doi-asserted-by":"crossref","unstructured":"Bashari WA, Senanayake R, Fernandez-Pombo A, Gillett D, Koulouri O, Powlson A, et al. Extended TSS (guided by 11C-methionine PET + MRI (Met-PET\/MRCR)) can be an effective treatment option for patients with persistent acromegaly due to previously deemed unresectable lateral disease. In BioScientifica; 2019 [cited 2020 May 15]","DOI":"10.1530\/endoabs.65.OP6.1"},{"issue":"9","key":"899_CR11","doi-asserted-by":"publisher","first-page":"e3236","DOI":"10.1210\/clinem\/dgaa444","volume":"105","author":"V Bonert","year":"2020","unstructured":"Bonert V, Mirocha J, Carmichael J, Yuen KCJ, Araki T, Melmed S. Cost-effectiveness and efficacy of a novel combination regimen in acromegaly: a prospective. Randomized Trial J Clin Endocrinol Metab. 2020;105(9):e3236\u201345.","journal-title":"Randomized Trial J Clin Endocrinol Metab"},{"issue":"3","key":"899_CR12","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1111\/j.1365-2265.2011.04200.x","volume":"76","author":"F Gatto","year":"2012","unstructured":"Gatto F, Barbieri F, Gatti M, Wurth R, Schulz S, Ravetti J-L, et al. Balance between somatostatin and D2 receptor expression drives TSH-secreting adenoma response to somatostatin analogues and dopastatins. Clin Endocrinol (Oxf). 2012;76(3):407\u201314.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"899_CR13","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1097\/RLU.0000000000000272","volume":"39","author":"S Hassler","year":"2014","unstructured":"Hassler S, Ben-Sellem D, Hubele F, Constantinesco A, Goetz C. Dual-isotope 99mTc-MIBI\/123I parathyroid scintigraphy in primary hyperparathyroidism: comparison of subtraction SPECT\/CT and pinhole planar scan. Clin Nucl Med. 2014;39(1):32\u20136.","journal-title":"Clin Nucl Med"},{"issue":"2","key":"899_CR14","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1111\/j.1528-1167.2012.03686.x","volume":"54","author":"A Desai","year":"2013","unstructured":"Desai A, Bekelis K, Thadani VM, Roberts DW, Jobst BC, Duhaime A-C, et al. Interictal PET and ictal subtraction SPECT: Sensitivity in the detection of seizure foci in patients with medically intractable epilepsy. Epilepsia. 2013;54(2):341\u201350.","journal-title":"Epilepsia"},{"issue":"10","key":"899_CR15","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/j.braindev.2013.08.011","volume":"35","author":"K Haginoya","year":"2013","unstructured":"Haginoya K, Uematsu M, Munakata M, Kakisaka Y, Kikuchi A, Nakayama T, et al. The usefulness of subtraction ictal SPECT and ictal near-infrared spectroscopic topography in patients with West syndrome. Brain Dev. 2013;35(10):887\u201393.","journal-title":"Brain Dev"},{"issue":"3","key":"899_CR16","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1046\/j.1528-1157.2003.29402.x","volume":"44","author":"CW Koo","year":"2003","unstructured":"Koo CW, Devinsky O, Hari K, Balasny J, Noz ME, Kramer EL. Stratifying differences on ictal\/interictal subtraction SPECT images. Epilepsia. 2003;44(3):379\u201386.","journal-title":"Epilepsia"},{"issue":"2","key":"899_CR17","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.eplepsyres.2008.08.007","volume":"82","author":"KM Tan","year":"2008","unstructured":"Tan KM, Britton JW, Buchhalter JR, Worrell GA, Lagerlund TD, Shin C, et al. Influence of subtraction ictal SPECT on surgical management in focal epilepsy of indeterminate localization: a prospective study. Epilepsy Res. 2008;82(2):190\u20133.","journal-title":"Epilepsy Res"},{"key":"899_CR18","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3389\/fninf.2018.00094\/full","volume":"12","author":"A Marcoux","year":"2018","unstructured":"Marcoux A, Burgos N, Bertrand A, Teichmann M, Routier A, Wen J, et al. An automated pipeline for the analysis of PET data on the cortical surface. Front Neuroinform. 2018;12:2. https:\/\/doi.org\/10.3389\/fninf.2018.00094\/full.","journal-title":"Front Neuroinform"},{"issue":"7","key":"899_CR19","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.2967\/jnumed.113.136432","volume":"55","author":"A Perissinotti","year":"2014","unstructured":"Perissinotti A, Setoain X, Aparicio J, Rub\u00ed S, Fuster BM, Donaire A, et al. Clinical role of subtraction ictal SPECT coregistered to MR imaging and 18F-FDG PET in pediatric epilepsy. J Nucl Med. 2014;55(7):1099\u2013105.","journal-title":"J Nucl Med"},{"issue":"222","key":"899_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2020.117229","volume":"15","author":"FJ L\u00f3pez-Gonz\u00e1lez","year":"2020","unstructured":"L\u00f3pez-Gonz\u00e1lez FJ, Silva-Rodr\u00edguez J, Paredes-Pacheco J, Ni\u00f1erola-Baiz\u00e1n A, Efthimiou N, Mart\u00edn-Mart\u00edn C, et al. Intensity normalization methods in brain FDG-PET quantification. Neuroimage. 2020;15(222): 117229.","journal-title":"Neuroimage"},{"key":"899_CR21","doi-asserted-by":"crossref","unstructured":"Garali I, Adel M, Bourennane S, Guedj E. Region-based brain selection and classification on pet images for Alzheimer\u2019s disease computer aided diagnosis. In: 2015 IEEE international conference on image processing (ICIP). 2015. p. 1473\u20137.","DOI":"10.1109\/ICIP.2015.7351045"},{"key":"899_CR22","first-page":"255","volume-title":"Oxford handbook of endocrinology & diabetes","author":"M Gurnell","year":"2022","unstructured":"Gurnell M, Koulouri O, Bashari W. Thyrotropinomas. In: Owen K, Turner H, Wass J, editors. Oxford handbook of endocrinology & diabetes. 4th ed. Oxford: Academic Press; 2022. p. 255\u201363.","edition":"4"},{"key":"899_CR23","first-page":"261","volume-title":"Encyclopedia of endocrine diseases","author":"O Koulouri","year":"2019","unstructured":"Koulouri O, Gurnell M. TSH-secreting pituitary adenomas. In: Huhtaniemi I, Martini L, editors. Encyclopedia of endocrine diseases, vol. 2. 2nd ed. Oxford: Academic Press; 2019. p. 261\u20136.","edition":"2"},{"issue":"1","key":"899_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1530\/EJE-20-0484","volume":"184","author":"F Illouz","year":"2021","unstructured":"Illouz F, Chanson P, Sonnet E, Brue T, Ferriere A, Raffin Sanson ML, Vantyghem MC, Raverot G, Munier M, Rodien P, Briet C. Somatostatin receptor ligands induce TSH deficiency in thyrotropin-secreting pituitary adenoma. Eur J Endocrinol. 2021;184(1):1\u20138. https:\/\/doi.org\/10.1530\/EJE-20-0484.","journal-title":"Eur J Endocrinol"},{"issue":"9","key":"899_CR25","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1016\/j.mri.2012.05.001","volume":"30","author":"A Fedorov","year":"2012","unstructured":"Fedorov A, Beichel R, Kalpathy-Cramer J, Finet J, Fillion-Robin J-C, Pujol S, et al. 3D Slicer as an image computing platform for the Quantitative Imaging Network. Magn Reson Imaging. 2012;30(9):1323\u201341.","journal-title":"Magn Reson Imaging"},{"issue":"3","key":"899_CR26","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1002\/mp.13970","volume":"47","author":"X Xiong","year":"2020","unstructured":"Xiong X, Linhardt TJ, Liu W, Smith BJ, Sun W, Bauer C, et al. A 3D deep convolutional neural network approach for the automated measurement of cerebellum tracer uptake in FDG PET-CT scans. Med Phys. 2020;47(3):1058\u201366.","journal-title":"Med Phys"},{"key":"899_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/cen.14425","volume":"00","author":"A Tj\u00f6rnstrand","year":"2021","unstructured":"Tj\u00f6rnstrand A, Casar-Borota O, Heurling K, et al. Pre- and postoperative 68Ga-DOTATOC positron emission tomography for hormone-secreting pituitary neuroendocrine tumours. Clin Endocrinol (Oxf). 2021;00:1\u201312. https:\/\/doi.org\/10.1111\/cen.14425.","journal-title":"Clin Endocrinol (Oxf)"}],"container-title":["EJNMMI Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13550-022-00899-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13550-022-00899-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13550-022-00899-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,7]],"date-time":"2022-05-07T12:17:58Z","timestamp":1651925878000},"score":1,"resource":{"primary":{"URL":"https:\/\/ejnmmires.springeropen.com\/articles\/10.1186\/s13550-022-00899-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,7]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["899"],"URL":"https:\/\/doi.org\/10.1186\/s13550-022-00899-7","relation":{},"ISSN":["2191-219X"],"issn-type":[{"value":"2191-219X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,7]]},"assertion":[{"value":"7 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all individual participants included in the study. This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the National Research Ethics Service (NRES) London Fulham Committee (28\/9\/14\u2014Reference: 14\/LO\/1642).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"26"}}